e-learning
resources
Vienna 2009
Monday, 14.09.2009
Severe sepsis and multiple organ failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat
S. Huang, X. Guan (Guangzhou, China)
Source:
Annual Congress 2009 - Severe sepsis and multiple organ failure
Session:
Severe sepsis and multiple organ failure
Session type:
Oral Presentation
Number:
2801
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Huang, X. Guan (Guangzhou, China). Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat. Eur Respir J 2009; 34: Suppl. 53, 2801
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
CD101 eosinophil serves as an early response to suppress endotoxin-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Immunotherapy improves inflammatory cytokines, humoral immunity and cellular immunity in septic patients
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010
Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
Monocyte inflammatory responsiveness and potential therapeutic target for pigeon fancier‘s hypersensitivity pneumonitis (HP)
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Role of altered immune response in CF and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Successful treatment of lung inflammation is associated with elevation of lymphocyte sensitivity to glucocorticoids
Source: Eur Respir J 2001; 18: Suppl. 33, 433s
Year: 2001
Targeting AMPK and the Nrf2/HO-1 axis: a promising therapeutic strategy in acute lung injury
Source: Eur Respir J, 58 (6) 2102238; 10.1183/13993003.02238-2021
Year: 2021
Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
From ineffective tumor immune response to immunomodulation in lung cancer
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017
The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019
The role of pro-inflammatory cytokine activation in perioperative lung injury
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004
Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses.
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Tim-3 regulates Tregs’ ability to resolve the inflammation and proliferation of acute lung injury by polarizing M2c macrophages
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Therapeutic potential of mesenchymal stem cells to attenuate immune cell tolerance in a late stage model of sepsis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept